Influenza Vaccine Market Projected to Reach Over USD 7.2 Billion by 2031

The global influenza vaccine market is poised for significant growth from 2023 to 2031, driven by various factors such as the surge in flu prevalence, increased awareness, a growing geriatric population, and government initiatives promoting vaccination. The market, valued at US$ 4.0 billion in 2022, is projected to grow at a CAGR of 7.2% during this period, reaching over US$ 7.2 billion by 2031.

Market Overview

Influenza vaccines, also known as flu shots, play a crucial role in preventing and controlling the spread of the influenza virus. They are available in inactivated and live attenuated forms, with valency options of quadrivalent and trivalent, catering to both pediatric and adult populations. The market is witnessing a surge in the number of collaborations between market players and governments to ensure the availability of flu vaccines, particularly in remote areas, which is expected to accelerate market development.

Download Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=211

Market Size and Growth

The market is witnessing a rapid pace of growth, attributed to the introduction of new vaccines and increased adoption in developing and underdeveloped countries. The introduction of new, highly effective influenza vaccines by major pharmaceutical companies, such as Pfizer and Moderna, is expected to bolster market development. Additionally, the rise in the number of collaborations between market players and governments is propelling market growth.

Market Segmentation

The market is segmented based on type (inactivated and live attenuated), valency (quadrivalent and trivalent), and age group (pediatric and adult). Inactivated vaccines, which are made from dead strains of the flu virus, dominated the market in 2022, offering a high level of safety and making them an ideal option for people at higher risk of serious complications from the flu. Furthermore, quadrivalent vaccines, protecting against four strains of the flu virus, dominated the market in 2022, offering better protection and increased effectiveness in preventing the flu.

Customization Request for the Research Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=211

Regional Analysis

North America is one of the largest markets for influenza vaccines, driven by a high incidence of flu and well-established healthcare infrastructure. The market in Asia Pacific is also emerging, driven by the growing burden of flu and improving healthcare infrastructure. The rise in awareness about the importance of flu vaccination and the increase in availability of vaccines are accelerating market growth in this region.

Market Drivers and Challenges

The market is being driven by factors such as the surge in flu prevalence, increased awareness, a growing geriatric population, and government initiatives promoting vaccination. However, challenges such as volatility in raw material prices, high cost of flu vaccines, and limited awareness and access in developing countries are expected to hamper market progress.

Market Trends and Future Outlook

Key market trends include the adoption of inactivated vaccines for people at higher risk of complications from flu, the dominance of quadrivalent vaccines, and the availability of influenza vaccines in hospitals and pharmacies. Looking ahead, the market is expected to witness significant growth, driven by the introduction of new vaccines and increased adoption in developing and underdeveloped countries.

Competitive Landscape and Recent Developments

Key players in the market include Pfizer, Inc., Sanofi, GlaxoSmithKline (GSK), AstraZeneca, Merck & Co., Inc., Novartis AG, Roche Holding AG, Seqirus (CSL Limited), Johnson & Johnson, and Daiichi Sankyo Company, Limited. These players are adopting strategies such as product launches, mergers & acquisitions, and partnerships to strengthen their position in the market.

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=211<ype=S

More Trending Report by Transparency Market Research:

Pulmonary Arterial Hypertension Market - https://www.globenewswire.com/en/news-release/2018/07/24/1541108/0/en/Pulmonary-Arterial-Hypertension-Market-to-reach-a-valuation-of-US-5-19-Bn-by-2020-Says-TMR.html

Intraocular Lens Market - https://www.globenewswire.com/en/news-release/2023/09/26/2749655/32656/en/Intraocular-Lens-Market-Predicted-to-Reach-USD-5-6-billion-by-2028-Expanding-at-a-4-9-CAGR-Exclusive-Report-by-Transparency-Market-Research.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Nikhil Sawlani

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

This release was published on openPR.